ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

This adverse event was reported 654 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY:

# Drug Count
0 ADALIMUMAB 544
1 METHOTREXATE SODIUM 523
2 TOCILIZUMAB 516
3 DICLOFENAC SODIUM 513
4 DICLOFENAC 510
5 METHOTREXATE 507
6 ETANERCEPT 498
7 FOLIC ACID 496
8 DESOXIMETASONE 494
9 ADALIMUMAB-ADAZ 492
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRICLOSAN 84 0.1673
1 TRIPROLIDINE HYDROCHLORIDE 17 0.0966
2 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 48 0.0791
3 CLEAR MINT, GEL TOOTHPASTE 70 0.0674
4 SODIUM FLUORIDE F18 70 0.0669
5 SODIUM FLUORIDE F-18 70 0.0667
6 BACITRACIN AND POLYMYXIN B SULFATE 1 0.0667
7 CAFFEINE CITRATE 145 0.0665
8 DICLOFENAC POTASSIUM TABLETS 376 0.0470
9 BACITRACIN ZINC AND POLYMYXIN B SULFATE 4 0.0381
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY